Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

ACC 2023 | RENOVATE-COMPLEX-PCI: Intravascular Imaging-Guided vs. Angiography-Guided Complex PCI

Patients with complex coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI) have worse clinical outcomes tan patients with non-complex CAD. Several studies have shown that the use of intravascular imaging (IVUS, OCT) have reduced major adverse events vs. angiography guided PCI. However, these studies present limitations both of size, studied population, short term followup and selection bias. 

Angioplastia compleja guiada por IVUS vs angiografía

The aim of this prospective, randomize, open label and multicenter study of superiority was to determine whether intravascular imaging guided PCI might improve clinical outcomes vs. angioplasty guided PCI in patients with complex CAD. 

Primary end point was target vessel failure (TVF) defined as a composite of cardiac death, target vessel MI and clinically driven target vessel revascularization. 

Researchers looked at 1639 patients randomized to intravascular imaging guided PCI N=1092) and angiography guided PCI (N=547). Mean age was 65 and patients were mostly men. 

The most frequent clinical presentation was acute coronary syndrome (ACS) (50.8%), and unstable angina was the most prevalent (32.6%). Complex coronary lesions were defined as long lesions (54.8%), multivessel lesions (37.9%), bifurcations (21.9%), chromic total occlusions (19.5%), multiple stents (18.6%), ostial lesions (15.3%), instent restenosis (14.4%), severe calcification (14.1%) and unprotected left main PCI (11.7%). IVUS was used more often (74.5%).

Read also: ACC 2023 | TAVR in Low Risk Patients: 3-Year Outcomes.

TVF in the intravascular imaging guided PCI was 7.7% vs 12.3% in the angioplasty guided PCI (HR: 0.64; 95% CI, 0.45 – 0.89; P=0.008). When comparing OCT vs IVUS guided PCI, there were no differences in TVF at one year (P=0.248).

Conclusion 

Among patient with complex CAD, the use of intravascular imaging guided PCI was associated with lower incidence of cardiac death, target vessel MI or clinically driven revascularization vs angioplasty guided PCI. The RENOVATE-COMPLEX-PCI supports the use of intravascular imaging guided PCI in the treatment of patients with complex CAD. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular Imaging-Guided Versus Angiography-Guided Complex PCI. The RENOVATE-COMPLEX-PCI Trial.

Reference: Joo-Yong Hahn, MD, PhD et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

EuroPCR 2026 | TAVI in Women: Do Supra-Annular Valves Offer a True Hemodynamic Advantage?

Women represent a particularly challenging population for TAVI, as they often have smaller aortic annuli, greater frailty, and an increased risk of prosthesis-patient mismatch....

EuroPCR 2026 | TAVI or Surgery in Younger Patients? Quality of Life and 3-Year Outcomes from NOTION-2

The expansion of TAVI into younger and lower surgical-risk populations has sparked a new debate: beyond mortality and stroke, which strategy provides better functional...

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...